Cindy Perettie
About Cindy Perettie
Cindy Perettie serves as the Executive Vice President at Kite Pharma, where she leads global efforts in oncology. With extensive experience in the biotechnology sector, she has held various leadership roles, including CEO of Foundation Medicine and President of Global Development Innovations at Sarah Cannon Research Institute.
Current Role at Kite Pharma
Cindy Perettie serves as the Executive Vice President at Kite Pharma, a position she has held since 2023. In this role, she is responsible for leading the company's global initiatives in cell therapy. Her leadership is focused on advancing research efforts to improve outcomes in cancer treatment. Perettie's extensive experience in the biotechnology sector contributes to her strategic vision for Kite, where she aims to foster innovation and growth.
Previous Leadership at Foundation Medicine
Prior to her current role, Cindy Perettie was the Chief Executive Officer of Foundation Medicine from 2019 to 2021. Following her tenure as CEO, she served as Chairman of the Board from 2021 to 2023. During her time at Foundation Medicine, she played a critical role in shaping the company's direction and enhancing its impact in the field of precision medicine.
Educational Background
Cindy Perettie holds a Master of Business Administration (MBA) with a focus on Marketing and Finance from Saint Mary's College of California, which she attended from 1995 to 1997. She also earned a Bachelor of Science degree in Biology with a minor in Chemistry from the State University of New York College at Potsdam, where she studied from 1983 to 1987. Additionally, she studied at The Johns Hopkins University from 1987 to 1989, further enhancing her academic credentials.
Diverse Professional Experience
Cindy Perettie has a diverse professional background that spans various roles in the biotechnology and pharmaceutical industries. She has held significant positions at Genentech, including Vice President of Global Regulatory Operations and Clinical/Safety Documentation, and Vice President of Global Product Strategy in Hematology. Her experience also includes leadership roles at Roche and Sarah Cannon Research Institute, providing her with a comprehensive perspective on the industry from research to patient care.
Personal Motivation and Interests
Cindy Perettie's work in oncology is motivated by personal experiences with cancer in her family, driving her commitment to making a meaningful impact in cancer treatment. Outside of her professional life, she enjoys various outdoor activities, including hockey, basketball, hiking, biking, and skiing, often engaging in these activities with her family. Sports have played a significant role in her life, fostering teamwork skills and lifelong friendships.